Apricell Biotechnology

Apricell Biotechnology is a private Canadian biotechnology and life science tools company developing hydrogel-based 3D tissue culture and organoid platforms for cancer research, drug screening, and personalized medicine. Its core products include the 3-in-1 Platform, TruSphere Platform, and HTSphere Platform, which are designed to generate reproducible spheroid and organoid models for in vitro testing and downstream analysis. The company also offers contract research services built on these proprietary platforms, supporting drug efficacy testing, toxicology, and disease modeling for academic and pharmaceutical customers. Apricell's technology is positioned to improve the predictive value of preclinical oncology testing by better modeling tumor biology and reducing reliance on animal studies.